[Pj-101] Japanese Poster Session 101　Neuromuscular junction disease　(MG：Treatment 3) | 66th Annual Meeting of the Japanese Society of Neurology

Advanced Search

Session Details

Japanese Poster Session

[Pj-101]Japanese Poster Session 101　Neuromuscular junction disease　(MG：Treatment 3)

Sat. May 24, 2025 1:30 PM - 2:50 PM JST
Sat. May 24, 2025 4:30 AM - 5:50 AM UTC

ポスター会場(大阪国際会議場3F イベントホール)

Chair: Kiyokazu Kawabe（Saiseikai Yokohamashi Tobu Hospital, Japan）

[Pj-101-1]Clinical management of myasthenia gravis patients with Efgartigimod: a seven case series

Akari Takagi, Kenji Yoshimura, Hirokazu Morihata, Takahiro Mitsueda (Osaka City General Hospital, Japan)

[Pj-101-2]Changes in non-oral therapies and real-world evaluation of FcRn inhibitors in myasthenia gravis

Takao Kiriyama, Akito Tanaka, Hitoki Nanaura, Naohiko Iguchi, Hironori Shimizu, Kana Hamada, Naoya Kikutsuji, Nobuyuki Eura, Kazuma Sugie (Nara Medical University, Department of Neurology, Japan)

[Pj-101-3]Study on Maintenance Therapy for Patients with Myasthenia Gravis in a Rehabilitation Hospital

Ryusei Nagata, Hitoshi Arata, Hideki Okatsu, Kimiyoshi Arimura (Okatsu Hospital, Japan)

[Pj-101-4]Assessment by new fatigue scales in patients with generalized MG treated with rozanolixizumab

Moeko Arai^1,2, Genya Watanabe², Naoyuki Tokashiki², Tatsuo Miyamoto², Kenichi Tsukita², Yasushi Suzuki² (1.Osaki Municipal Hospital Kashimadai Branch, Japan, 2.National Hospital Organization Sendai Medical Center, Japan)

[Pj-101-5]A study of cases of refractory MuSK antibody-positive myasthenia gravis treated with FcRn inhibitors

Rie Kuroda¹, Ryotaro Ikeguchi¹, Mutsumi Iijima¹, Yuko Shimizu^1,2, Kenichi Todo¹ (1.Department of Neurology, Tokyo Women's Medical University, Japan, 2.Department of Medical Safety, Tokyo Women's Medical University, Japan)

Back to Category List